5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.82▲ | 7.80▲ | 7.78▲ | 7.94▼ | 7.24▲ |
MA10 | 7.79▲ | 7.77▲ | 7.84▲ | 7.59▲ | 7.60▲ |
MA20 | 7.77▲ | 7.86▲ | 7.93▼ | 7.21▲ | 7.41▲ |
MA50 | 7.89▲ | 7.86▲ | 7.58▲ | 7.63▲ | 8.11▼ |
MA100 | 7.98▼ | 7.39▲ | 7.23▲ | 7.57▲ | N/A |
MA200 | 7.51▲ | 7.15▲ | 7.45▲ | 7.97▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.023▲ | -0.005▼ | -0.041▼ | 0.143▲ | 0.025▲ |
RSI | 59.272▲ | 53.329▲ | 53.968▲ | 57.433▲ | 51.141▲ |
STOCH | 89.815▲ | 65.227 | 28.237 | 73.727 | 35.333 |
WILL %R | 0.000▲ | -35.802 | -55.932 | -31.356 | -34.933 |
CCI | 247.995▲ | 104.637▲ | 18.160 | 74.102 | 50.566 |
Tuesday, September 23, 2025 05:00 PM
HC Wainwright restated their buy rating on shares of Actuate Therapeutics (NASDAQ:ACTU – Free Report) in a report issued on Tuesday morning,Benzinga reports. They currently have a $20.00 price ...
|
Thursday, September 11, 2025 01:01 PM
CHICAGO and FORT WORTH, Texas, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
|
Wednesday, September 10, 2025 05:31 AM
CHICAGO and FORT WORTH, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/10/25 | 7.91 | 7.91 | 7.91 | 7.91 | 927 |
15/10/25 | 8.15 | 8.20 | 7.63 | 7.83 | 82,267 |
14/10/25 | 8.09 | 8.2652 | 7.58 | 8.09 | 55,311 |
13/10/25 | 8.035 | 8.3037 | 7.91 | 8.09 | 52,918 |
10/10/25 | 8.17 | 8.49 | 7.665 | 7.79 | 137,982 |
09/10/25 | 7.105 | 8.13 | 7.085 | 8.09 | 169,518 |
08/10/25 | 7.07 | 7.38 | 7.00 | 7.01 | 54,375 |
07/10/25 | 7.08 | 7.10 | 6.87 | 7.04 | 27,600 |
06/10/25 | 6.97 | 7.12 | 6.82 | 7.02 | 27,923 |
03/10/25 | 6.76 | 7.03 | 6.75 | 6.98 | 43,200 |
|
|
||||
|
|
||||
|
|